15
Views
6
CrossRef citations to date
0
Altmetric
Special Report

Allergic contact dermatitis from topical medicaments

&
Pages 37-42 | Published online: 10 Jan 2014

References

  • Brandão FM, Goossens A, Tosti A. Chapter 35: topical drugs. In: Contact Dermatitis. Frosh PJ, Menné T, Lepoittevin JP (Eds). Springer, Berlin Heidelberg, NY, USA,623–652 (2006).
  • Mirshahpanah P, Maibach HI. Relationship of patch test positivity in a general versus an eczema population. Contact Derm.56, 125–130 (2007).
  • Morris SD, Rycroft RJG, White IR, Wakelin SH, McFadden JP. Comparative frequency of patch test reactions to topical antibiotics. Br. J. Dermatol.146, 1047–1051 (2002).
  • Menezes de Pádua CA, Uter W, Schnuch A. Contact allergy to topical drugs: prevalence in a clinical setting and estimation of frequency at the population level. Pharmacoepidemiol. Drug Saf.16, 377–384 (2007).
  • Saap L, Fahim S, Arsenault E et al. Contact sensitivity in patients with leg ulcerations. Arch. Dermatol.140, 1241–1246 (2004).
  • Yang Tang B, Jin Goon A, Hian Leow Y. Contact sensitization in patients with chronic venous leg ulcers in Singapore. Contact Derm.56, 94–98 (2007).
  • Bashir SJ, Maibach HI. Compound allergy: an overview. Contact Derm.36, 179–183 (1997).
  • Turchin I, Moreau L, Warshaw E, Sasseville D. Cross-reactions among parabens, para-phenylenediamine, and benzocaine: a retrospective analysis of patch testing. Dermatitis17, 192–195 (2006).
  • Fernando G. Contact dermatitis from prilocaine with cross-sensitivity to pramocaine and bupivacaine. Contact Derm.56, 120–121 (2007).
  • Langan SM, Collins P. Photocontact allergy to oxybenzone and contact allergy to lignocaine and prilocaine. Contact Derm.54, 173–174 (2006).
  • De Castro Martinez FJ, Ruiz FJ, Tornero P, De Barrio M, Prieto A. Systemic contact dermatitis due to fusidic acid. Contact Derm.54, 169 (2006).
  • Schalock PC, Zug KA. Bacitracin. Cutis76, 105–106 (2005).
  • Wetter DA, Davis MD, Yiannias JA et al. Patch test results from the Mayo Clinic Contact Dermatitis Group. J. Am. Acad. Dermatol.53, 416–421 (2005).
  • Aberer W. Bacitracin for lubrication: an allergen for more convenience? J. Am. Acad. Dermatol.52, 1114–1115 (2005).
  • Barbaud A, Vigan M, Delrous JL et al. Contact allergy to antiseptics: 75 cases analyzed by the dermato-allergovigilance network. Ann. Dermatol. Venereol.132, 962–965 (2005).
  • Lee SK, Zhai H, Maibach HI. Allergic contact dermatitis from iodine preparations: a conundrum. Contact Derm.52, 184–187 (2005).
  • Tanaka T, Satoh T, Yokozeki H. Allergic contact dermatitis from luliconazole: implication of the dithioacetal structure. Acta Derm. Venereol.87, 271–272 (2007).
  • Shono M. Allergic contact dermatitis from luliconazole. Contact Derm.56, 296–297 (2007).
  • Serpentier-Daude A, Collet E, Didier AF, Touraud JP, Sgro C, Lambert D. Contact dermatitis to topical antiviral drugs. Ann. Dermatol. Venereol.127, 191–193 (2000).
  • Amon RA, Lis AW, Hanifin JM. Allergic contact dermatitis caused by idoxuridine. Arch. Dermatol.111, 1581–1584 (1975).
  • Walker S, Ferguson JE. Systemic allergic Contact dermatitis due to ethylenediamine following administration of oral aminophylline. Br. J. Dermatol.150, 594 (2004).
  • Ash S, Scheman AJ. Systemic contact dermatitis to hydroxyzine. Am. J. Contact Dermat.8, 2–5 (1997).
  • Cusano F, Ferrara G, Crisman G, Sarracco G, Zalaudek I, Argenziano G. Clinicopathologic features of systemic contact dermatitis from ethylenediamine in cetirizine and levocetirizine. Dermatology213, 353–355 (2006).
  • Nettis E, Colanardi MC, Calogiuri GF, Ferrannini A, Vacca A, Tursi A. Allergic reactions to inhalant glucocorticosteroids: a hot topic for pneumologists and allergologists. Immunopharmacol. Immunotoxicol.28, 511–534 (2006).
  • Davis M, el-Azhary R, Farmer S. Results of patch testing to a corticosteroid series: a retrospective review of 1188 patients during 6 years at Mayo Clinic. J. Am. Acad. Dermatol.56, 921–927 (2007).
  • Coopman S, Degreef H, Dooms-Goossens A. Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids. Br. J. Derm.121, 27–34 (1989).
  • Matura M, Goossens A. Contact allergy to corticosteroids. Allergy55, 698–704 (2000).
  • Jacob SE, Steele T. Corticosteroid classes: a quick reference guide including patch test substances and cross-reactivity. J. Am. Acad. Dermatol.54, 723–727 (2006).
  • Wilkinson SM. Corticosteroid cross-reactions: an alternative view. Contact Derm.42, 59–63 (2000).
  • Isaksson M, Brandão FM, Bruze M, Goossens A. Recommendation to include budesonide and tixocortol pivalate in the European standard series. Contact Derm.43, 41–42 (2000).
  • Isaksson M. Corticosteroid contact allergy – the importance of late readings and testing with corticosteroids used by the patients. Contact Derm.56, 56–57 (2007).
  • Diaz RL, Gardeazabal J, Manrique P et al. Greater allergenicity of topical ketoprofen in contact dermatitis confirmed by use. Contact Derm.54, 239–243 (2006).
  • Veyrac G, Paulin M, Milpied B, Bourin M, Jolliet P. Bilan de l’enquéte nationale sur les effets indésirables cutanés du kétoprofèn gel enregistrés entre le 01/09/1996 et le 31/08/ 2000. Therapie57, 55–64 (2002).
  • Durbize E, Vigan M, Puzenat E et al. Spectrum of cross-photosensitization in 18 consecutive patients with contact photoallergy to ketoprofen: associated photoallergies to non-benzophenone-containing molecules. Contact Derm.48, 144–149 (2003).
  • Pitarch Bort G, de la Cuadra Oyanguren J, Torrijos Aguilar A, García-Melgares Linares ML. Allergic contact dermatitis due to aceclofenac. Contact Derm.55, 365–366 (2006).
  • Musel AL, Warshaw EM. Cutaneous reactions to transdermal therapeutic systems. Dermatitis17, 109–122 (2006).

Website

  • Agence Française de Securité Sanitaire des Produits de Santé. Gels de kétoprofène et réactions de photosensibilité. Presented at: Communiqué 7 July 2003 www.afssaps.santefr/htm/10/filltrpsc/lp030701.htm

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.